The Clermont-Ferrand University Hospital hosts CAP Poumons, a lung cancer awareness stand
As part of a lung cancer awareness initiative, the Clermont-Ferrand University Hospital will host an information stand to raise awareness among patients and healthcare professionals about lung cancer on Friday, 28 November, from 11:00 a.m. to 2:30 p.m., in the Gabriel-Montpied site hall.
A multidisciplinary team from the University Hospital will be present at the CAP Poumons stand, supported by MSD-France Laboratory, to answer patients’ and their families’ questions about prevention and disease management.
The team will include onco-pulmonologists, oncologists, nurses, a tobacco cessation nurse, an adapted physical activity educator, a socio-beautician, and more.
A carbon monoxide breath test may also be offered to provide an assessment.
During the event, the general public will also have the opportunity to learn about the pilot screening program “Impulsion,” led by the French National Cancer Institute and supported in Clermont-Ferrand by Dr. Patrick Merle, head of the thoracic oncology care unit, in collaboration with the Hospices Civils de Lyon.
The program, which will begin enrolling patients in March 2026, aims to assess the optimal conditions for implementing an organized lung cancer screening program in France for a target population (ages 50 to 75, with a history of smoking more than 20 pack-years or having quit less than 15 years ago).
Learn More
Lung cancer is the leading cause of cancer-related death in France (30,893 deaths in 2022 according to INCa), with a low survival rate (~20% at 5 years). Its incidence is stable among men but rising sharply among women, despite major therapeutic advances (notably immunotherapy). It is the second most common cancer in men and the third most common in women.
80% of cases are linked to tobacco use in all its forms, and passive smoking also increases risk. Quitting smoking is part of the treatment plan to reduce the risk of complications during and after treatment, recurrence, secondary cancer, and to improve quality of life.
And at Clermont-Ferrand University Hospital?
At the CHU of Clermont-Ferrand, the thoracic and medical oncology department treats over 300 new patients per year, at all stages of the disease—from diagnosis to treatment—including palliative and functional care, provided by a dedicated team.
